Research location
Baden-Baden
Germany
Advertisement
Research activity in Baden-Baden
GermanyCureCurrent currently publishes aggregate city-level research activity for this location: 31 trials and 33 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Baden-Baden
31 linked trials · page 1 of 1PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanNCT05573893 · 2023-09-12 · 1 site observation
RECRUITING
Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NASTNCT04101851 · 2021-01-13 · 1 site observation
ACTIVE_NOT_RECRUITING
First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.NCT04767594 · 2020-10-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid ArthritisNCT04497597 · 2020-10-16 · 1 site observation
COMPLETED
The Effectiveness Of Atezolizumab In Patients With Locally-Advanced Or Metastatic Non-Small Cell Lung Cancer After Prior ChemotherapyNCT03559647 · 2018-05-30 · 1 site observation
COMPLETED
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First LineNCT03462251 · 2018-05-24 · 1 site observation
COMPLETED
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or FulvestrantNCT02894398 · 2016-09-06 · 1 site observation
COMPLETED
Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation TherapyNCT02173769 · 2014-06-01 · 1 site observation
COMPLETED
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast CancerNCT02032823 · 2014-04-22 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Serelaxin Versus Standard of Care in Acute Heart Failure (AHF) PatientsNCT02064868 · 2014-01-31 · 1 site observation
TERMINATED
An Open Label Study for Participants With Rheumatoid ArthritisNCT01215942 · 2011-06-01 · 1 site observation
TERMINATED
A Study in Participants With Rheumatoid ArthritisNCT01202773 · 2011-01-01 · 1 site observation
TERMINATED
Addition of Rituximab to Leflunomide in Patients With Active Rheumatoid ArthritisNCT01244958 · 2010-08-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe Chronic Obstructive Pulmonary Disease (COPD) (DACOTA)NCT01285167 · 2010-08-01 · 1 site observation
COMPLETED
Quality of Life in Daxas-treated Patients Older Than 18 Years With Severe COPDNCT01285180 · 2010-08-01 · 2 site observations
COMPLETED
A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid ArthritisNCT01119859 · 2010-05-01 · 1 site observation
COMPLETED
Assessment of Chronic Obstructive Pulmonary Disease (COPD) Therapy From the Physicians Perspective Using Tiotropium as an ExampleNCT01036763 · 2010-01-01 · 1 site observation
COMPLETED
A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid ArthritisNCT01007435 · 2009-10-31 · 1 site observation
COMPLETED
Observation of Treatment With Certolizumab Pegol in Daily PracticeNCT01069419 · 2009-10-01 · 1 site observation
COMPLETED
A Study to Assess Efficacy With Respect to Clinical Improvement in Disease Activity and Safety of Tocilizumab in Patients Wtih Active Rheumatoid Arthritis.NCT00754559 · 2008-08-01 · 1 site observation
COMPLETED
Observational Non-Interventional Study With Spiriva Respimat in COPD PatientsNCT00699699 · 2008-06-01 · 1 site observation
COMPLETED
ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063DNCT00490139 · 2007-05-16 · 1 site observation
COMPLETED
Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's DiseaseNCT00539214 · 2007-03-01 · 1 site observation
COMPLETED
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk HypertensivesNCT00539487 · 2007-01-01 · 2 site observations
COMPLETED
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)NCT00299546 · 2006-02-01 · 1 site observation
COMPLETED
Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment RegimensNCT00149214 · 2005-09-01 · 1 site observation
COMPLETED
A Long-term Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients With Rheumatoid ArthritisNCT00721123 · 2005-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of Adalimumab in Patients With Rheumatoid Arthritis in Routine Clinical PracticeNCT01077258 · 2004-04-01 · 1 site observation
COMPLETED
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast CancerNCT00066703 · 2003-11-03 · 1 site observation
COMPLETED
Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical PracticeNCT01078090 · 2003-04-01 · 1 site observation
COMPLETED
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid ArthritisNCT00106548 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.